632
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Anti-Proliferative Activity of Extracts from Thai Plantsin Guttiferae and Schisandraceae Families on HumanCancer Cell Lines

, &
Pages 255-258 | Accepted 16 Oct 2006, Published online: 07 Oct 2008
 

Abstract

Twenty-two methanol and chloroform crude extracts from Guttiferae (Hypericum hookerianum. Wight & Arn; Garcinia speciosa. Wall; Garcinia xanthochymus. Hook. F. ex T. Anderson; Cratoxylum formosum. subsp. pruniflorum. (Kurz) Gogel; and Calophyllum polyanthum. Wall ex Choisy) and Schisandraceae families (Schisandra verruculosa. Gagnap) collected from the northern region of Thailand were tested for antiproliferative activity on B16F10 (melanoma), HeLa (cervical carcinoma), and KB (epidermoid carcinoma) human cancer cell lines using the sulforhodamine-B (SRB) binding assay. All crude extracts showed an interesting antiproliferative activity with a dose-response relationship. The chloroform extract from leaves of G. speciosa. was the most potent in inhibiting cancer cell growth with the GI50 of 4, 6.6, and 3.7 µg/mL in HeLa, KB, and B16F10 cell lines, which were 13-, 20- and 142-fold less potent than doxurubicin, respectively. The information from this study can explain the use of these plants in Thai traditional medicine and suggests the potential for further development of these extracts to new pharmaceuticals.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.